The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Dec. 26, 2017
Applicant:

Sun-bio Medical Device Co., Ltd., Tokyo, JP;

Inventors:

Yang Yang, Shanghai, CN;

Wei Yin, Wuhan, CN;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/22 (2006.01); C07K 16/32 (2006.01); A61K 39/395 (2006.01); A61P 35/00 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39558 (2013.01); A61P 35/00 (2018.01); C07K 16/22 (2013.01); C07K 16/32 (2013.01); C12N 15/79 (2013.01); C07K 2317/31 (2013.01); C07K 2317/32 (2013.01); C07K 2317/622 (2013.01);
Abstract

A bispecific antibody that simultaneously targets humanized p185 and VEGF, consisting of the four peptide chains: two identical antibody light chains that are the light chains of the antibody that identify the epitope or antigen of p185, and two identical antibody heavy chains that have the amino acid sequence of a recombinant antibody from N- to C-terminus, a light chain sequence of the antibody that recognizes the p185 epitope or the antigen; a constant heavy chain region; a flexible short peptide sequence; and either a single-stranded variable region sequence (ScFv) of anti-VEGF antibody which recognizes the VEGF epitope or antigen, or a receptor domain sequence that binds to VEGF. The bispecific antibody has the ability to bind p185 and VEGF at the same time, inhibits the proliferation of tumor cells, and promotes the expression of IFN-γ by T lymphocytes; it may be applied as anti-tumor antibody drug.


Find Patent Forward Citations

Loading…